General F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing BoomBy Healthcare Propulsion StaffJuly 24, 20260 A Food and Drug Administration advisory panel recommended broader use of six unproven peptides, raising concerns that wellness and telehealth…
